Ami Organics Limited (AMIORG) is an R&D driven manufacturer of speciality chemicals focused on two business segments, mainly pharmaceuticals advance intermediates also known as pharma intermediates and specialty chemicals. Under pharma intermediates, it manufactures Active Pharmaceuticals Ingredients (APIs) and New Chemical Entity (NCEs). It has developed and commercialized over 450 pharma intermediates for APIs across all 17 therapeutic areas and for New Chemical Entities. Under its Speciality Chemical segment, the company manufactures key starting raw materials for Agrochemicals and Fine Chemicals companies. It has recently acquired two facilities from Gujarat Organics Ltd. (GOL), which help to foray into preservatives and other specialty chemicals used in manufacturing of cosmetics, dye, polymers and agrochemicals. Ami Organics is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban which find application in certain high-growth therapeutic areas, commanding significant market share both in India and globally.
OutlookWith the presence in high growing and niche markets Ami Organics Limited is set to continue to post better growth in mid term. We initiate our coverage on the stock with a BUY rating and a target price of ₹1,354 Per Share
For all recommendations report, click hereDisclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
Read More
